IRB Home | Historic Research | Federal Regulations | Sladen Library
 
  Welcome
Ethical Research Practice
Institutional Review Board

IRB Review Criteria
--Definition of Research
--Is It Research?
--Human Subjects
--Case Study 1
--Case Study 2
--Study Design
--Minimal Risk
--Risks & Benefits
--Confidentiality
--HIPAA
--Subject Selection
--Vulnerable Subjects
--Incentives
--Quiz

Informed Consent
Genetic Testing
Types of Review
Continuation & Final Reports
Serious Adverse Events
Frequently Asked Questions
Conclusion

Risks & Benefits

Often cutting edge research involves extremely ill patients who are willing to take the risk of side-effects or other risks without any guarantees of benefiting from the drug or procedures. It is the responsibility of the research investigators to consider the risk/benefit ratio carefully when designing research that explores uncharted territory and to investigate all possible knowledge available to the scientific community prior to conducting experimental research.

Informed consent is a very important part of research. The IRB will carefully consider the potential risk/benefit ratio when there is no known treatment for conditions. Subjects should always be informed of other treatment options and not unduly influenced to pursue experimental treatment that involves high risk.

<<< Back